Author name: amit

Kondor Pharma Presents Its Clinical Trial Data on Alzheimer’s Patients

Dr. Laurent Balenci, COO of Kondor Pharma today presented the result of our pilot clinical trial of Inflawell on patients with mild and moderate Alzheimer’s disease (AD), at the 3rd Canadian Neuroscience Innovation Summit. A randomized double-blind placebo-controlled trial on 80 Alzheimer’s patients indicated significant improvement in memory and cognition in Inflawell group compared to …

Kondor Pharma Presents Its Clinical Trial Data on Alzheimer’s Patients Read More »

Kondor Pharma Establishes New Subsidiary, HealthWeX Inc.

Kondor Pharma today announced establishing a new subsidiary, HelathWeX Inc. The company will provide pre-clinical and clinical trial services to nutraceutical and pharmaceutical industry clients. HealthWeX will assemble a team of clinicians and scientists to develop programs and services around our core strength of conducting clinical trials for neurological diseases. Other areas of interest currently …

Kondor Pharma Establishes New Subsidiary, HealthWeX Inc. Read More »

Neuroinflammation & Functional Connectivity in Alzheimer’s Disease

Neuroinflammation is becoming more center staged in Alzheimer’s. A research article published today in the Journal of Neuroscience demonstrated for the first time that neuroinflammation interrupts the neuronal connectivity in Alzheimer’s patients. The investigation led by Dr. Rowe at Medical Research Council, Cambridge UK, used brain imaging and biomarkers analysis. The study further proves the …

Neuroinflammation & Functional Connectivity in Alzheimer’s Disease Read More »

Scroll to Top